Isopropyl myristate - CAS 110-27-0
Catalog: |
BB002609 |
Product Name: |
Isopropyl myristate |
CAS: |
110-27-0 |
Synonyms: |
propan-2-yl tetradecanoate |
IUPAC Name: | propan-2-yl tetradecanoate |
Description: | Isopropyl myristate is an emollient ester of low viscosity for topical delivery of pharmaceuticals. |
Molecular Weight: | 270.45 |
Molecular Formula: | C17H34O2 |
Canonical SMILES: | CCCCCCCCCCCCCC(=O)OC(C)C |
InChI: | InChI=1S/C17H34O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-17(18)19-16(2)3/h16H,4-15H2,1-3H3 |
InChI Key: | AXISYYRBXTVTFY-UHFFFAOYSA-N |
Boiling Point: | 167 °C at 9 mmHg |
Melting Point: | -5°C |
Flash Point: | 29.6 dyne/cm Density: 0.864 g/cm³ |
Purity: | 98%+ |
Density: | 0.853 g/cm3 |
Solubility: | Soluble in chloroform (slightly), ethyl acetate (slightly). |
Appearance: | Clear colorless oil |
Storage: | Room Temperature |
Decomposition: | When heated to decomposition it emits toxic smoke and fumes |
MDL: | MFCD00008982 |
LogP: | 5.63910 |
Refractive Index: | 1.434-1.436 |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents. |
Vapor Pressure: | 0.000329mmHg at 25°C |
GHS Hazard Statement: | H315 (99.79%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P264, P280, P302+P352, P321, P332+P313, and P362 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
US-11033516-B1 | Combination therapies with disulfiram | 20200918 |
US-10836729-B1 | Metabolically stable 5-HMF derivatives for the treatment of hypoxia | 20200504 |
US-10836757-B1 | Polymorphic forms of metopimazine | 20200402 |
US-11007134-B1 | Ceramide containing capsules, ceramide compositions, and cosmetic compositions thereof | 20200331 |
US-10780139-B1 | Hypericum revolutum extract as a vasodilator | 20200319 |
PMID | Publication Date | Title | Journal |
28132900 | 20170501 | Influence of the penetration enhancer isopropyl myristate on stratum corneum lipid model membranes revealed by neutron diffraction and 2H NMR experiments | Biochimica et biophysica acta. Biomembranes |
22324326 | 20121201 | The influence of the structure and the composition of water/AOT-Tween 85/IPM microemulsion system on transdermal delivery of 5-fluorouracil | Drug development and industrial pharmacy |
22348223 | 20121201 | Artesunate-loaded chitosan/lecithin nanoparticles: preparation, characterization, and in vivo studies | Drug development and industrial pharmacy |
22928552 | 20121201 | The role of vehicle interactions on permeation of an active through model membranes and human skin | International journal of cosmetic science |
22972714 | 20121201 | Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron | Journal of pharmaceutical sciences |
Complexity: | 199 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 270.255880323 |
Formal Charge: | 0 |
Heavy Atom Count: | 19 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 270.255880323 |
Rotatable Bond Count: | 14 |
Topological Polar Surface Area: | 26.3 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 7.2 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS